Skip to main content
HANALL BIOPHARMA CO.,LTD logo

HANALL BIOPHARMA CO.,LTD — Investor Relations & Filings

Ticker · 009420 ISIN · KR7009420001 KO Manufacturing
Open in API
Filings indexed 327 across all filing types
Latest filing 2026-04-29 Transaction in Own Shar…
Country KR South Korea
Listing KO 009420

About HANALL BIOPHARMA CO.,LTD

http://www.hanallbiopharma.com/

HanAll Biopharma is a global biopharmaceutical company focused on developing innovative, first-in-class therapies for patients with unmet medical needs. The company's research and development efforts are centered on immunology, ophthalmology, and immuno-oncology, with a specialization in antibody-based therapeutics. Its pipeline includes novel treatments for autoimmune diseases and dry eye disease. The company's mission is to pioneer cutting-edge medicines that address incurable and immune-associated conditions. Alongside its innovative pipeline, HanAll Biopharma also operates a portfolio of pharmaceutical products in therapeutic areas including endocrine, circulatory, and urologic diseases.

Recent filings

Filing Released Lang Actions
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 1% confidence The document is a Korean Major Event Report (주요사항보고서) disclosing the company’s decision to dispose of treasury shares (“자기주식 처분 결정”). It details share quantities, disposal methods, purposes, counterparties, and pricing. This fits the category for Transaction in Own Shares (company share buybacks or disposals). Thus, it should be classified under POS.
2026-04-29 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 1% confidence The document is a fair‐value disclosure of consolidated provisional operating results (매출액, 영업이익, 당기순이익) for the first quarter of 2026 with period comparisons. It is a short summary of key quarterly financial highlights rather than a full interim report, and it mirrors an initial earnings announcement (“잠정 실적(공정공시)”). Therefore, it fits the definition of an Earnings Release (ER). Q1 2026
2026-04-29 Korean
기업설명회(IR)개최(안내공시)
Investor Presentation Classification · 1% confidence The document is an announcement regarding the scheduling and details of an upcoming investor relations (IR) presentation (roadshow), including date, venue, participants, purpose, and links to IR materials. It does not contain full financial results or slide decks itself but is clearly focused on an investor presentation event. This matches the “Investor Presentation” category (Code: IP).
2026-04-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 1% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서” – a report by a major shareholder (National Pension Service) disclosing its share ownership and changes (crossing the 10% threshold). This matches the Major Shareholding Notification category (MRQ). It is not an announcement of a report but the report itself detailing shareholdings, so MRQ is the correct classification.
2026-04-07 Korean
투자판단관련주요경영사항
Regulatory Filings Classification · 1% confidence The document is a Korean regulatory disclosure (‘투자판단 관련 주요경영사항’) detailing clinical trial Phase 3 top-line results for a drug. It contains substantive operational information, not an earnings release, governance document, or periodic financial report, nor merely an announcement that a formal report is attached. It does not match any specific category (e.g., annual/quarterly reports, capital changes, dividends, M&A, etc.) and thus falls into the general regulatory announcement fallback category RNS.
2026-04-02 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a Korean “주식등의 대량보유상황보고서(약식)” filed by 국민연금공단 (National Pension Service) disclosing changes in its shareholdings in 한올바이오파마. This corresponds to a notification of major shareholding level changes under Korean securities law. Among our categories, this matches “Major Shareholding Notification (Code: MRQ).”
2026-04-01 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.